Larimar Therapeutics (LRMR) Other Accumulated Expenses (2013 - 2026)
Larimar Therapeutics (LRMR) posted Other Accumulated Expenses of $1.32 million for Q2 2026, up 99.4% from $662,000 a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Larimar Therapeutics' Other Accumulated Expenses came in at $777,000, up 38.5% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 37.2% (FY2020 to FY2025).
- In prior years, Larimar Therapeutics' Other Accumulated Expenses was $561,000 in FY2024 (+31.4%), $427,000 in FY2023 (-3.2%), $441,000 in FY2022 (-2.4%) and $452,000 in FY2021 (+182.5%).
- The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses in data going back to Q4 2013.
- On a year-over-year basis, Other Accumulated Expenses increased in six of the last seven quarters, with growth averaging 32.5%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q3 2022, with growth of 416.6%; the weakest was Q2 2025, with a decline of 38.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Larimar Therapeutics | 307.49 Mn | -299.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Mn |
| Dec 31, 2025 | 777,000.00 |
| Sep 30, 2025 | 881,000.00 |
| Jun 30, 2025 | 662,000.00 |
| Mar 31, 2025 | 767,000.00 |
| Dec 31, 2024 | 561,000.00 |
| Sep 30, 2024 | 867,000.00 |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 506,000.00 |
| Dec 31, 2023 | 427,000.00 |
| Sep 30, 2023 | 602,000.00 |
| Jun 30, 2023 | 835,000.00 |
| Mar 31, 2023 | 476,000.00 |
| Dec 31, 2022 | 441,000.00 |
| Sep 30, 2022 | 780,000.00 |
| Jun 30, 2022 | 519,000.00 |
| Mar 31, 2022 | 512,000.00 |
| Dec 31, 2021 | 452,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 143,000.00 |
API Access
Larimar Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();